Emtriva Articles
Gilead's Emtriva wins EU approval
3 November 2003
Gilead starts Viread/Emtriva combi study
18 August 2003
Gilead signs deal with Japan Tobacco
11 August 2003
Gilead's Emtriva on track for EU approval
4 August 2003
Gilead's Emtriva shows efficacy at 60 wks
28 July 2003
Gilead Sciences set to beat expectations
21 July 2003
Gilead's Hepsera for hep B OKed in Europe
17 March 2003
Stock Commentary - Week to Feb 17 - New York
24 February 2003
Positive Ph III data with Triangle's emtricitabine
17 February 2003
Triangle's Coviracil trial "un-blinded"
5 August 2002
Losses reduced at Triangle Pharma
18 February 2002
Triangle to file one, drop one HIV drug
28 January 2002
Antivirals promise major rewards in hep B virus therapy: study.
21 January 2002
Triangle drugs for HBV make progress
15 November 2001
Correction: Triangle Pharmaceuticals
21 June 2000
Triangle seeks to lift halt on HIV drug
13 June 2000
New data with Triangle's emtricitabine
3 February 2000
Triangle slumps on FDA request for more Coactinon data
15 December 1999
Triangle's lead HIV drug shows promise
11 February 1999
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
